MS treatment optimization: report from the 21st ETRIMS/10th ACTRIMS Congress, 28 September-1 October 2005, Thessaloniki, Greece.
Around 3500 international delegates were presented with a broad scientific programme at the joint meeting of the 21st ECTRIMS and 10th ACTRIMS congress held last September. The meeting focused on the heterogeneity of MS and optimizing MS treatment--from the earliest stages to the long-term management of this chronic disease--with the goal of improving patient outcome.
Clanet
Michel
M
Hohlfeld
Reinhard
R
D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*
D007155:Immunologic Factors